Insider Shareholders with Direct Ownership of Harmony Biosciences Holdings, Inc. (HRMY)
This section provides a comprehensive overview of the insiders with direct ownership of Harmony Biosciences Holdings, Inc. (HRMY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Harmony Biosciences Holdings, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Valor Iv Pharma Holdings, Llc
> 10% Shareholder |
0 | 4,600,000 | 6,618,033 $257 Million | 2 |
Nov 05, 2024
Reduced 8.31%
|
|
Marshman Fund Trust Ii
> 10% Shareholder |
339,476 | 4,600,000 | 6,051,120 $235 Million | 3 |
Nov 05, 2024
Reduced 9.02%
|
|
Novo Holdings
> 10% Shareholder |
4,409,803 | 0 | 4,409,803 $171 Million | 1 |
Aug 21, 2020
Added 2.92%
|
|
Jeffrey S Aronin
Director |
251,922 | 0 | 251,922 $9.77 Million | 1 |
Dec 14, 2021
Added 50.0%
|
|
Jeffrey M. Dayno
PRESIDENT, CEO |
109,793 | 103,860 | 5,933 $230,081 | 22 |
Jan 24, 2025
Reduced 43.5%
|
|
Andrew Serafin
CHIEF STRATEGY OFFICER |
40,500 | 38,865 | 1,635 $63,405 | 4 |
Jan 24, 2025
Reduced 34.6%
|
|
Kumar Budur
CHIEF MEDICAL OFFICER |
2,187 | 1,151 | 1,036 $40,176 | 2 |
Jan 24, 2025
Reduced 52.63%
|
|
John C Jacobs
PRESIDENT, CEO |
200,000 | 200,000 | 0 $0 | 20 |
Aug 15, 2022
Reduced 100.0%
|
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
320,321 | 324,380 | 0 $0 | 52 |
Jan 27, 2025
Reduced 100.0%
|
|
Sandip Kapadia
CHIEF FINANCIAL OFFICER |
133,812 | 84,291 | 0 $0 | 11 |
Jan 27, 2025
Reduced 100.0%
|